Acadia Healthcare Company, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Acadia Healthcare Company, Inc. on May 11, 2015. The report details the completion of a public offering of common stock and the exercise of an underwriters' option.
Key Financial Metrics and Transaction Details
- Shares Sold: 4,500,000 Firm Shares plus 675,000 Option Shares (total 5,175,000 shares).
- Public Offering Price: $66.50 per share.
- Net Proceeds: Approximately $331.1 million (after underwriting discounts, commissions, and estimated offering expenses).
- Underwriters: Merrill Lynch, Pierce, Fenner & Smith Incorporated and Jefferies LLC.
Material Changes and Use of Proceeds
The filing reports the completion of the sale of Firm Shares and Option Shares on May 11, 2015. The company intends to utilize the net proceeds for the following purposes:
- Repayment of outstanding indebtedness on the senior secured revolving line of credit under its amended and restated senior credit agreement.
- Funding acquisition activity.
- General corporate purposes.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, outlook, or management commentary beyond the stated use of proceeds. No specific risks or contingencies related to the offering are detailed in this excerpt, other than the standard execution of the underwriting agreement.
Key Facts for Investor Verification
- Verify the exact amount of debt repaid from the $331.1 million net proceeds.
- Confirm the specific acquisition activities funded by these proceeds.
- Review the full underwriting agreement for details on lock-up periods or additional terms.
- Check subsequent filings for the impact of this capital raise on the company's balance sheet and liquidity position.